Bone pastes comprising biofunctionalized calcium phosphate cements with enhanced cell functions for bone repair
The invention provides injectable, biofunctional agent-containing calcium phosphate cement bone pastes for bone tissue engineering, and methods of making and using the same.
1. A bone paste comprising calcium phosphate cement, one or more biofunctional agents and stem cells, wherein the biofunctional agents are selected from the group consisting of RGD-containing peptides, fibronectin, fibronectin-like engineered polymer protein (FEPP), derived extracellular matrix (dECM), and platelet concentrate, and wherein the stem cells are selected from the group consisting of human umbilical cord mesencchymal stem cells, bone marrow stem cells, embryonic stem cells, pluripotent stem cells, induced pluripotent stem cells, multipotent stem cells, progenitor cells, and osteoblasts.
2. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, an RGD-containing peptide and stem cells, wherein RGD-containing peptide is selected from the group consisting of RGD, G4RGDSP, RGDS, GRGD, GRGDGY, RGDSGGC, and GRGDS, and wherein RGD-containing peptide is present within a range of about 0.0005% to about 5% by mass.
3. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, fibronectin and stem cells, wherein fibronectin is present within a range of about 0.0005% to about 5% by mass.
4. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, FEPP and stem cells, wherein FEPP is present within a range of about 0.0005% to about 5% by mass.
5. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, and stem cells, wherein dECM is present within a range of about 0.001% to about 10% by mass.
6. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, platelet concentrate and stem cells, wherein platelet concentrate is present within a range of about 0.001% to about 10% by mass.
7. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, any two of the biofunctional agents and stem cells.
8. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, any three of the biofunctional agents and stem cells.
9. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, any four of the biofunctional agents and stern cells.
10. The bone paste of claim 1 , wherein the bone paste comprises calcium phosphate cement, each of the five biofunctional agents and stem cells.
11. The bone paste of claim 1 , wherein the calcium phosphate cement comprises one or more ingredients selected from the group consisting of tetracalcium phosphate (TTCP) (Ca 4 (PO 4 ) 2 O), dicalcium phosphate anhydrous (DCPA) (CaHPO 4 ), dicalcium phosphate dihydrate (CaHPO 4 .2H 2 O), tricalcium phosphate (Ca 3 [PO 4 ] 2 ), α-tricalcium phosphate (α-Ca 3 (PO 4 ) 2 ), β-tricalcium phosphate (β-Ca 3 (PO 4 ) 2 ), octacalcium phosphate (Ca 8 H 2 (PO 4 ) 6 . 5H 2 O), amorphous calcium phosphate (Ca 3 (PO 4 ) 2 ), calcium carbonate (CaCO 3 ), calcium hydroxide (Ca[OH] 2 ), and hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ), and mixtures thereof.
12. The bone paste of claim 1 , wherein the calcium phosphate cement comprises tetracalcium phosphate and dicalcium phosphate anhydrous.
13. The bone paste of claim 12 , wherein the calcium phosphate cement comprises a molar ratio of tetracalcium phosphate to dicalcium phosphate anhydrous of about 1:5 to about 5:1.
14. The bone paste of claim 1 , wherein the calcium phosphate cement further comprises chitosan, degradable fibers, or both chitosan and degradable fibers.
15. The bone paste of claim 1 , wherein the calcium phosphate cement further comprises a porogen.
16. The bone paste of claim 14 , wherein the bone paste comprises calcium phosphate cement, a RGD-containing peptide and stem cells, wherein the RGD-containing peptide is present within a range of about 0.0005% to about 0.05% by mass of the bone paste, and wherein the RGD-containing peptide is covalently linked to said chitosan.
17. The bone paste of claim 1 , wherein the cells are attached to a surface of the bone paste, or the cells are interspersed throughout the bone paste, or both.
18. The bone paste of claim 1 , wherein the stem cells are encapsulated in microbeads.
19. The bone paste of claim 18 , wherein the microbeads are hydrogel microbeads.
20. The bone paste of claim 19 , wherein the microbeads are comprised of alginate, partially oxidized alginate, oxidized alginate, alginate-fibrin, partially oxidized alginate-fibrin, oxidized alginate-fibrin, poly(ethylene glycol diacrylate), poly(ethylene glycol)-anhydride dimethacrylate, gelatin, chemically cross-linked polymers, ionically cross-linked polymers, heat-polymerized polymers, or photopolymerized polymers.
21. The bone paste of claim 18 , wherein the microbeads are alginate-fibrin microbeads, and wherein the alginate-fibrin microbeads comprise a fibrinogen mass fraction of from about 0.05% to about 1%.
22. The bone paste of claim 21 , wherein the alginate is at about 7.5% oxidation.
23. The bone paste of claim 18 , wherein the microbeads have an average diameter of less than about 2 millimeters.